Thong-Gyu Jin,Yo Kyung Chung,Sang Hoon Paik,Yoo Chang Park,Jinwook Seo,Yong Woon Choi,Jong Mun Son,Yong-Chul Kim
申请号：
US14128918
公开号：
US09206402B2
申请日:
2012.06.15
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
